IMAC has a strong track record of successful submissions that secure reimbursement for our valued clients. We join your team—giving you flexible and direct access to our highly experienced senior consultants.
International Market Access Consulting (IMAC) is a collective of senior consultants, each a specialist in their field, who not only offer strategic advice but also perform the hands-on work to deliver results. Our clients benefit from direct access to these senior professionals throughout every engagement, ensuring a high level of expertise and consistency from start to finish.
Founded in 2006 in Switzerland and expanded to North America in 2009, IMAC was created with a vision to change the way market access services were delivered. Frustrated with her experiences at larger vendors—where meetings were held with senior executives, but the actual work was handed off to junior staff—our founder, Louise Perrault, set out to create something different. IMAC was established with a unique commitment: clients would work directly with senior experts who have decades of experience and who personally execute all project work.
IMAC is a leader in securing market access for rare disease therapies, with deep expertise in overcoming the unique regulatory and access challenges these conditions present. Our team develops compelling value propositions, targeted evidence generation strategies, and comprehensive reimbursement dossiers to support successful product launches in rare disease markets across Europe and globally.
Our team has extensive experience guiding successful HTA submissions to public and private payers, with a strong focus on European markets. We have a proven track record working with agencies such as NICE, HAS, G-BA, and AIFA, securing positive outcomes for innovative health technologies. With a deep understanding of the critical nuances in these complex assessments, we ensure our clients’ submissions are strategically tailored to meet each agency’s specific requirements.
With the rising demand for RWE, IMAC offers expert guidance in designing and executing studies that meet the needs of European payers and regulators. Our consultants bring extensive knowledge in observational research, registry data, and the integration of RWE into market access strategies, ensuring your product’s real-world value is effectively communicated to drive access and acceptance.
IMAC is a global leader in market access, with deep-rooted expertise across Europe and proven success in North America, Australia, and Asia. Our team has a profound understanding of the complex healthcare systems, payer landscapes, and regulatory requirements in these regions, enabling us to navigate diverse market access challenges with precision.
We excel in crafting tailored strategies that address unique local and regional demands while maintaining a unified global approach. With over 18 years of experience, our seasoned experts work directly with you to secure market access for innovative therapies, delivering impactful results in even the most challenging environments.